Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK Gains Clarity For Pharma Focus Through Novartis Consumer JV Buy

Executive Summary

GSK removed some uncertainty about how much it could invest in pharma R&D and business development by purchasing Novartis' share of the firms' Consumer Healthcare Joint Venture. Now it can more accurately allocate capital as it prepares for battle in HIV and braces for Advair generics.

Advertisement

Related Content

GSK Exercises Right To Buy Out Novartis Consumer Healthcare JV For $13bn
GSK Drops Out Of Auction For Pfizer's Consumer Health Unit
Gilead's Biktarvy Approval Heightens HIV Competition With ViiV
Walmsley: GSK Is 'Prepared' And 'Ready' For US Advair Generic Launch
Shingrix Seen Replacing Zostavax In EU & US as Shingles Standard Of Care
Walmsley Takes On Oncology: Can GSK Become A Power Player?
GSK Bags Barron As R&D Boss As Vallance Joins UK Government
Trelegy Approval Boosts GSK's US Respiratory Business But Pressure Remains
Glaxo Set To File Nucala In COPD, Despite Mixed Phase III Results
Novartis in $28.5bn+ mega-deal with GSK, Lilly

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC100646

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel